Semaglutide
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 150
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide 2.4 mg | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
| Semaglutide, on treatment | n/r | n/r | n/r | n/r | n/r |
| Placebo, on treatment | 7 participants | 2 participants | 3 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.